Nordisk Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 42852287
Stenkløvervænget 21, 2625 Vallensbæk
Income statement (kDKK)
2022 | 2023 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | -18.80 | 331.91 |
EBIT | -18.80 | 331.91 |
Other financial expenses | -0.20 | |
Pre-tax profit | -19.00 | 331.91 |
Income taxes | -68.93 | |
Net earnings | -19.00 | 262.98 |
Assets (kDKK)
2022 | 2023 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Investments total | ||
Long term receivables total | ||
Raw materials and consumables | 60.38 | |
Inventories total | 60.38 | |
Current trade debtors | 250.12 | |
Current other receivables | 0.58 | |
Short term receivables total | 0.58 | 250.12 |
Cash and bank deposits | 320.44 | 436.10 |
Cash and cash equivalents | 320.44 | 436.10 |
Balance sheet total (assets) | 321.02 | 746.60 |
Equity and liabilities (kDKK)
2022 | 2023 | |
---|---|---|
Share capital | 340.00 | 340.00 |
Retained earnings | -19.00 | |
Profit of the financial year | -19.00 | 262.98 |
Shareholders equity total | 321.00 | 583.98 |
Non-current liabilities total | ||
Current trade creditors | 16.25 | |
Short-term deferred tax liabilities | 68.93 | |
Other non-interest bearing current liabilities | 0.03 | 77.45 |
Current liabilities total | 0.03 | 162.62 |
Balance sheet total (liabilities) | 321.02 | 746.60 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.